SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: OldAIMGuy who wrote (1144)11/27/2006 11:25:14 AM
From: tuck  Read Replies (1) of 1154
 
>>8:34AM Oscient Pharma (OSCID) says FDA accepts as "Complete Response'' OSCI's submission following Factive approvable letter for 5-day CAP (OSCI) 6.58 : OSCID says the FDA has accepted as complete it's response to the Factive tablets approvable letter for the application seeking approval for the five-day treatment of community-acquired pneumonia of mild to moderate severity. Factive is currently approved by the FDA for the five-day treatment of acute exacerbations of chronic bronchitis and the seven-day treatment of CAP.<<

Courtesy of Briefing.com.

Not sure what their odds are of changing the FDA's mind, but it's good for a few pennies in today's very negative market. Obviously, approval would be huge.

Cheers, Tuck
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News